Skip to main content

Autoinflammatory Disease

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Imagine Pharma
Imagine PharmaPA - Pittsburgh
1 program
Are Mast Cells Involved in Autoinflammatory DiseasesN/A1 trial
Active Trials
NCT05292768Not Yet Recruiting590Est. Oct 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Imagine PharmaAre Mast Cells Involved in Autoinflammatory Diseases

Clinical Trials (1)

Total enrollment: 590 patients across 1 trials

NCT05292768Imagine PharmaAre Mast Cells Involved in Autoinflammatory Diseases

Are Mast Cells Involved in Autoinflammatory Diseases

Start: Mar 2022Est. completion: Oct 2026590 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.